CRO Featured Services
Conjugation Process R&D
Linker and Payload R&D
Home > News> Press Releases > Text
Zencore Biologics announced the completion of 100 million RMB ($14.74 Million) Series C+ funding.
20400 Century Blvd, Suite 100, Germantown, MD 20874, USA
Building 26 and 27, Lane 500, Furonghua Road, Pudong New Area, China
Building 6, 860 Xinyang Road, Lin-gang Special Area, China (Shanghai) Pilot Free Trade Zone
289 Zhengjia Road, Lin-gang Special Area, China (Shanghai) Pilot Free Trade Zone
3F, Building B, No. 1976 Middle Gaoke Road, Pudong New District, Shanghai, China
Building 31(F1), 356 Zhengbo Road, Fengxian District, Shanghai, China
Wechat Official Account
Copyright © Zencore Biologics. All rights reserved.